Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Audax Mezzanine is the private debt and mezzanine financing arm of Audax Group, a leading alternative investment manager focused on the middle market. The firm provides subordinated debt and equity co-investments to support leveraged buyouts, add-on acquisitions, and recapitalizations. Audax Mezzanine maintains a significant presence in the healthcare and life sciences sectors, providing capital to companies in healthcare services, medical technology, and pharmaceutical services. By partnering with private equity sponsors, the firm helps drive growth and operational improvements in its portfolio companies. Since its founding in 1999, Audax has established itself as one of the most active investors in the North American middle market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Audax Mezzanine.